Exploring Ways to Destroy Cancer Cells More Effectively with Radiation Therapy

Author
lsm.lv

October 29, 2026

medicine research

How can cancer cells be destroyed as effectively as possible in radiation therapy for oncological diseases? This is what young physicist Kristaps Paļskis investigated in his doctoral thesis using accelerator technologies. It is currently an experimental approach to radiation therapy that would make it possible to irradiate harmful cancer cells with great precision and in an extremely short time, while minimising damage to healthy cells. The results obtained provide a theoretical basis for future innovations in radiation therapy.

Doktorantūras programmas students Kristaps Paļskis
Kristaps Paļskis, a student in the joint doctoral programme in Particle Physics of Riga Technical University and the University of Latvia. Photo: LETA, Kaspars Krafts
Milliseconds Instead of Minutes

Kristaps Paļskis, a student in the joint doctoral programme in Particle Physics of Riga Technical University (RTU) and the University of Latvia, examines in his doctoral thesis methods for delivering radiation to cancer patients during radiation therapy as quickly and precisely as possible. This is known as the FLASH effect, which has also been widely studied in recent years.

“In conventional therapy, we deliver the radiation over a timescale of minutes, whereas here the entire radiation dose – and one considerably higher than in conventional therapy – would be delivered within a few hundred milliseconds. I also examined this from a technological perspective: how to deliver the radiation so quickly while ensuring very precise dose delivery, how the patient is positioned, and how the patient’s internal physiological movements and similar factors must also be controlled with great precision.”

The young physicist acknowledges that his work has mostly involved programming and mathematical simulations, while chemical experiments were carried out at the German Cancer Research Center. He has mainly worked at the European Organization for Nuclear Research (CERN), where a dedicated working group is exploring how accelerator technologies can be applied in cancer treatment and how conventional X-ray radiation can be replaced with heavier particles – protons, helium ions and carbon ions. In his research, Paļskis has focused specifically on the potential use of helium ions.

“In principle, the patient would benefit from the fact that we would affect the cancer cells in the same way as with conventional radiation therapy, but the advantage of the speed is that the side effects, or the harmful effects of radiation on the surrounding healthy tissues, would be significantly reduced. Of course, clinical trials still lie ahead, because this is only the beginning of the journey. Theoretically, by reducing the impact on the surrounding healthy tissues, we could increase the dose delivered to the tumour while potentially keeping the side-effect profile at the same level as with conventional therapy.”

The researcher emphasises that the theoretical results obtained are only a small piece of the puzzle in making cancer treatment more precise, with modern technologies also being introduced in the future.

“The conventional radiation therapy equipment we use needs to be upgraded. In principle, with X-ray radiation as it is currently delivered using linear accelerators, the FLASH effect has not yet been observed. It is not the case that we can simply achieve this high dose rate and apply it in the usual way, because the volume to which we can deliver it is often limited, as the full technological capabilities are not yet available.”

Precision Needs to Be Improved

Maija Radziņa, Tenure Professor at Rīga Stradiņš University and Vice-President of the Latvian Association of Radiologists, notes that the findings of every researcher are important for further studies on cancer treatment. Current radiation therapy technologies already make it possible to direct the radiation beam precisely at the tumour and from different positions, but it is essential to continue improving this precision, the professor acknowledges.

“Sometimes it is much more important for us to achieve this precision literally down to the millimetre, for example when dealing with brain tumours or tumours somewhere in the facial area. Every tiny structure is located next to another vitally important structure, such as nerves or centres responsible for movement or sensation. That is where precision becomes critically important, and this is where accelerator technologies come in. Such therapies are already being developed around the world, but here in Latvia we currently do not yet have such advanced acceleration capabilities. And that is what Kristaps has been studying – how we could build such devices in the future and exactly which particles we should use, because these particles really need space and distance in which to accelerate in order to reach their maximum effective power,” Radziņa said.

In developing his doctoral thesis, Paļskis involved several students from the Faculty of Civil and Mechanical Engineering at RTU, who also had the opportunity to work at CERN.

Recommended articles

medicine space quantum technologies

State Research Programme “Defence Innovation Research Programme” for 2026–2029 Announced

Based on Paragraph 17 of Cabinet Regulation No. 560 of 4 September 2018, “Procedures for the Implementation of State Research Programme Projects”, the Latvian Council of Science announces an open call for project applications under the State Research Programme “Defence Innovation Research Programme…

Latvian Council of Science

October 28, 2026

medicine public health

RSU Innovation Day to Showcase Solutions for Healthcare and Sport

On 5 November this year, Rīga Stradiņš University (RSU) will host Innovation Day, bringing together researchers, entrepreneurs, students and cooperation partners. At the event, university researchers will present emerging solutions in diagnostics, drug development and sport, while entrepreneurs and…

Rīga Stradiņš University

October 28, 2026

medicine biomedicīna pētniecība

National Institute of Research and Innovation: Synergy Between Chemistry and Biomedicine

The National Institute of Research and Innovation (NIRI) is a European-level life and natural sciences research centre in Latvia, established in the summer of 2026 through the merger of the Latvian Institute of Organic Synthesis (OSI) and the Latvian Biomedical Research and Study Centre (BMC). The …

National Institute of Research and Innovation

October 26, 2026

natural sciences humanities and arts medicine

AMBER HORIZONS — Upcoming Research and Academic Career Opportunities at the University of Latvia

The University of Latvia invites outstanding researchers with significant scientific achievements to explore upcoming Associate Professor opportunities within the AMBER HORIZONS programme, which is part of the Marie Skłodowska-Curie Actions initiative “Choose Europe for Science”. The Universit…

University of Latvia

October 26, 2026